Aseem Anand
About
In The Last Decade
Aseem Anand
16 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Pulmonary and Respiratory Medicine 1.7k
- Oncology 1.0k
- Cancer Research 1.0k
- Molecular Biology 593
- Radiology, Nuclear Medicine and Imaging 397
Countries citing papers authored by Aseem Anand
This map shows the geographic impact of Aseem Anand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aseem Anand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aseem Anand more than expected).
Fields of papers citing papers by Aseem Anand
This network shows the impact of papers produced by Aseem Anand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aseem Anand. The network helps show where Aseem Anand may publish in the future.
Co-authorship network of co-authors of Aseem Anand
This figure shows the co-authorship network connecting the top 25 collaborators of Aseem Anand. A scholar is included among the top collaborators of Aseem Anand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aseem Anand. Aseem Anand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 29 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 83 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 318 | |
| 10 | Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study breakdown → | 809 |
| 11 | 93 | |
| 12 | Fluorescence in situ hybridization analysis of circulating tumor cells in metastatic prostate cancer. | 11 |
| 13 | 116 | |
| 14 | 151 | |
| 15 | 53 | |
| 16 | 284 | |
| 17 | Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer breakdown → | 522 |
| 18 | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.